Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1128-1133

  Roux, Christian ^a   Oriente, Pasquale ^f   Laan, Roland ⁱ   Hughes, Rodney Andrey ^g   Ittner, Jochen ^j   Goemaere, Stefan ^h   Di Munno, Ombretta ^e   Pouillés, Jean Michel ^c   Horlait, Stéphane ^d   Cortet, Bernard ^b  

^a Hôpital Cochin ^*  (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CHU RANGUEIL   (France)

^d Procter Gamble Pharmaceut France   (France)

^e UNIVERSITY OF PISA   (Italy)

^f Nuovo Policlinico   (Italy)

^g Guilford Hospital   (United Kingdom)

^h Universiteits Ziekenhuis Gent   (Belgium)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM CARBONATE; CORTICOSTEROID; CREATININE; DEOXYPYRIDINOLINE; ETIDRONIC ACID; OSTEOCALCIN; PLACEBO; PREDNISONE; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE REMODELING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; FEMALE; FEMUR NECK; GASTROINTESTINAL TOXICITY; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 15144361569     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.4.4742     Document Type: Article

References (48)

1. Lukert BP, Raisz LG. 1940 Glucocorticoid - induced osteoporosis: Pathogenesis and management. Ann Int Med. 112:352-364.
2. Sambrook P, Birmingham J, Kempler S, et al. 1990 Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 5:1211-1216.
3. Adinoff AD, Hollister JR. 1983 Steroid induced fractures and bone loss in patients with asthma. N Engl J Med. 309:265-268.
4. Hooyman JR, Melton LJ, Nelson AM, O'Fallon WM, Riggs BL. 1984 Fractures after rheumatoid arthritis. A population based study. Arthritis Rheum. 27:1353-1361.
5. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. 1991 Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 46:803-806.
6. Cooper C, Coupland C, Mitchell M. 1995 Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Ann Rheum Dis. 54:49-52.
7. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. 1946 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. Br Med J. 313:344-346.
8. Dempster DW. 1989 Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 4:137-141.
9. Sambrook PN, Eisman JA, Champion GD, Pocock NA. 1988 Sex hormone status and osteoporosis in post menopausal women with rheumatoid arthritis. Arthritis Rheum. 31:973-478.
10. Lukert BP, Adams JS. 1976 Calcium and phosphorus homeostasis in man. Effect of corticosteroids. Arch Intern Med. 136:1249-1253.
11. Suzuki Y, Ichikawa Y, Saito E, Homma M. 1983 Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism. 32:151-156.
12. Paz-Pacheco E, El-Hajj Fuleihan G, Leboff MS. 1995 Intact parathyroid hormone levels are not elevated in glucocorticoid treated subjects. J Bone Miner Res 10:1713-1718.
13. Chen TL, Feldman D. 1978 Glucocorticoid potentiation of the adenosine 3′, 5′-monophosphate response to parathyroid hormone in cultured rat bone cells. Endocrinology 12:589-596.
14. Yamamoto I, Potts JT, Segre GV. 1988 Glucocorticoids increase parathyroid hormone receptors in rat osteoblastic osteosarcoma cells (Ros 17/2). J. Bone Miner Res 3:707-712.
15. Rizzoli R, Von Tschamer V, Fleisch H. 1986 Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblastic-like cells. Biochem J 237:447-454.
16. Gronowicz G, Mac Carthy MB, Raisz LG. 1990 Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro. J Bone Miner Res. 5:1223-1230.
17. Eggelmeijer F, Papapoulos SE, Westedt ML, Van Paassen HC, Dijkmans BAC, Breedveld FC. 1993 Bone metabolism in rheumatoid arthritis: relation to disease activity. Br J Rheumatol. 32:387-391.
18. Siris ES, Canfield RE, Jocobs TP, Baquiran DC. 1980 Long-term therapy of Paget's disease of bone with EHDP. Arthritis Rheum. 23:1177-1184.
19. Watts NB, Harris ST, Genant HK, et al. 1990 Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 323:73-79.
20. Adachi JD, Cranney A, Goldsmith CH, et al. 1994 Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol. 21:1922-1926.
21. Mulder H, Struys A. 1994 Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheum. 33:348-350.
22. Diamond T, Mc Guigan L, Barbagallo S, Bryant C. 1995 Cyclical etidronate plus ergocalciferol prevents glucocorticoid induced bone loss in post menopausal women. Am J Med. 98:459-463.
23. Struys A, Snelder AA, Mulder H. 1995 Cyclical etidronate preserves bone loss of the spine and proximal femur in patients with established corticosteroid induced osteoporosis. Am J Med. 99:235-242.
24. Looker AC, Wahner HW, Dunn WL, et al. 1995 Proximal femur bone mineral levels of US adults. Osteoporosis Int. 5:389-409.
25. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. 1994 The diagnosis of osteoporosis. J Bone Miner Res. 9:1137-1141.
26. Egsmose C, Daugaard H, Lund B. 1989 Determination of bone GLa protein (osteocalcin) by enzyme-linked immunosorbent assay. Clin Chim Acta. 184:279-287.
27. Pratt DA, Daniloff Y, Duncan A, Robins SP. 1992 Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase axtraction and reversed-phase high-performance liquid chromatography. Anal Biochem. 207:168-175.
28. Genant HK, Block JE, Steiger P, Gluer CC, Ettinger B, Harris ST. 1989 Appropriate use of bone densitometry. Radiology. 170:817-822.
29. American College of Rheumatology Task Force on Osteoporosis Guidelines. 1996 Recommendations for the prevention and treatment of glucocorticoid induced osteoporosis. Arthritis Rheum. 39:1791-1801.
30. Heaney RP. 1995 Interpreting trials of bone active agents. Am J Med. 98:329-330.
31. Adachi JD, Bensen WG, Bianchi F, et al. 1996 Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol. 23:995-1000.
32. Laan RFJM, Van Riel PLCM, Van de Putte LBA, Van Erning LJTO, Van't Hof MA, Lemmens JAM. 1993 Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized controlled study Ann Intern Med. 119:963-968.
33. Sambrook PN, Kelly PJ, Keaogh AM, et al. 1994 Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant. 13:116-121.
34. Chappard D, Legrand E, Basle MF, et al. 1996 Altered trabecular architecture induced by corticosteroid: a bone histomorphometric study. J Bone Miner Res. 11:676-685.
35. Sambrook P, Birmingham J, Kelly P, et al. 1993 Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol and calcitonin. N Engl J Med. 328:1747-1752.
36. Eastgate JA, Wood NC, Di Giovine FS, et al. 1988 Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 2:706-709.
37. Gowen M, Wood DD, Ihrie E, Mc Guire M, Russel RGG. 1983 An interleukin 1-like factor stimulates bone resorption in vitro. Nature. 306:378-380.
38. Beresford JN, Gallagher JA, Gowen M, et al. 1984 The effects of monocyte-conditioned medium and interleukin 1 on synthesis of collagenous and non collagenous proteins by mouse bone and human bone cells in vitro. Biochem Biophys Acta. 801:58-65.
39. Laan RFJM, Buijs WCAM, Verbeek ACM, et al. 1993 Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis. 52:21-26.
40. Hakala M, Risteli L, Manelins J, Nieminen P, Risteli J. 1993 Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis. 52:866-869.
41. Kollerup G, Hansen M, Horslev-Petersen K. 1994 Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheumatol. 33:816-820.
42. Meunier PJ, Dempster DW, Edouard C, et al. 1984 Bone histomorphometry in corticosteroid induced osteoporosis and Cushing's syndrom. Adv Exp Med Biol. 171:191-200.
43. Lukert BP, Higgins JC, Stoskopf MN. 1986 Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab. 62:1056-1058.
44. Kotowicz MA, Hall S, Hunder GG, Cedel SL, Mann KG, Riggs BL. 1990 Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum. 33:1487-1492.
45. Cosman F, Nievers J, Herbert J, Shen V, Lindsay R. 1994 High dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res. 9:1097-1105.
46. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab. 72:382-386.
47. Sambrook PN, Kelly PJ, Fontana D, et al. 1994 Mechanisms of rapid bone loss following cardiac transplantation. Osteoporosis Int. 4:273-276.
48. Adachi JD, Bensen WG, Brown J, et al. 1997 Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 337:382-387.